COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited
Coronavirus: PI Patients Look For Guidance
Head of the U.S. Immune Deficiency Foundation navigates uncertainty with fellow patients.
Podcast With CSL CEO Paul Perreault
“I want to make sure that we’re all supporting each other, practicing self-care, and if anybody reaches out, we’re there to t…
Work Continues for CSL Behring During the Pandemic
Patient groups praise U.S. guidelines that designate plasma centers, manufacturing sites as essential.
Podcast: Lessons from COVID-19
Biotech security leader shares his experiences on the front lines against the novel coronavirus.
On Being Brave
CSL Behring’s Ann-Marie Hulstine talks about her decision to donate a kidney to a near-stranger – and how to have courage in …
Videos on PI and Coronavirus Reach Thousands
Expert physician and adviser to the Immune Deficiency Foundation records regular video updates for primary immunodeficiency p…
We're Leading In Uncertain Times
These three principles can help you stay anchored to purpose, support your team and find a moment for yourself.
Short, sweet and once a week
Subscribe to get three stories each week about rare disease patients and biotech innovations.
Family Adopts a Son Who Has Hemophilia
Meet the Smith Family
A U.S. family opens their home, and hearts, to a new son who has hemophilia.